Showing 249 results

Filters Content type: News, Editors' picks, About HIV Topic: Injectable & long-acting HIV treatment

Research into injectable medications and other innovative forms of HIV treatment. It is hoped that they may only need to be taken every few weeks or months, rather than daily.

 

New & experimental HIV treatments

Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade

News
29 October 2020
Injectable & long-acting HIV treatment

Similar benefits and barriers to injectables for HIV prevention and treatment reported by US women

News
21 October 2020
Injectable & long-acting HIV treatment

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

Editor's pick
ViiV Healthcare press release
16 October 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
Injectable & long-acting HIV treatment

Long-acting injectables work without oral lead-in period

News
11 October 2020
Injectable & long-acting HIV treatment

Injectable HIV therapy should save money if adherence is better than to oral therapies

News
7 October 2020
Injectable & long-acting HIV treatment

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey

News
5 October 2020
Injectable & long-acting HIV treatment

Doravirine injections were safe and long-lasting, but did not reach therapeutic levels

News
4 August 2020
Coronavirus

aidsmapLIVE: AIDS 2020 special Video

July 2020
Injectable & long-acting PrEP

Injectable PrEP offers superior efficacy to oral PrEP in clinical trial

News
7 July 2020
Injectable & long-acting HIV treatment

ViiV Healthcare presents positive data from first-ever implementation research study on how best to integrate an investigational once-monthly injectable HIV treatment in US healthcare practices

Editor's pick
ViiV press release
4 July 2020
Injectable & long-acting HIV treatment

GSK says it is within weeks of resubmitting HIV injection Cabenuva

Editor's pick
Reuters
3 July 2020
New & experimental HIV treatments

Experimental HIV drug seems effective at a twice-a-year dose, study finds

Editor's pick
STAT
2 July 2020
Injectable & long-acting HIV treatment

Injectable antiretrovirals for HIV treatment or prevention: ambivalent views of potential users

News
26 May 2020
Injectable & long-acting HIV treatment

Women With HIV Interested in Long-Acting Injectable Treatment

Editor's pick
POZ
4 May 2020
Injectable & long-acting HIV treatment

Health Canada okays GSK unit's monthly HIV injection

Editor's pick
Reuters
23 March 2020
Injectable & long-acting HIV treatment

Long-acting injectables might be administered every two months

News
11 March 2020
Injectable & long-acting HIV treatment

Unitaid invests in long-acting medicines to simplify treatment and prevention for HIV, TB, malaria and HCV

Editor's pick
Unitaid
7 February 2020
Injectable & long-acting HIV treatment

No holiday gift for GSK: FDA sends long-acting HIV injectable back to work

Editor's pick
FiercePharma
24 December 2019
Injectable & long-acting HIV treatment

FDA Defers Approval of First Long-Acting HIV Therapy, Surprising Everyone

Editor's pick
HIV and ID Observations
23 December 2019
Injectable & long-acting HIV treatment

Effectiveness and frequency of dosing are the most important factors affecting acceptability of injectable HIV therapy, says US study

News
29 November 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
New & experimental HIV treatments

Oral cabotegravir and rilpivirine still effective at 312 weeks

News
14 October 2019